The US Food & Drug Administration approved the EMBLEM S-ICD system in 2012. Boston Scientific promotes the EMBLEM S-ICD as the only subcutaneous implantable cardioverter defibrillator (ICD) that is designed to protect from injuries caused by certain cardiac events or complications with transvenous leads.
Sep
06
Comments are closed.